Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2013
11/14/2013US20130303375 Plant growth regulating compounds
11/14/2013US20130303368 New compositions and methods for controlling nematode pests
11/14/2013US20130302422 Pharmaceutical composition for treatment and prevention of kidney diseases
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/13/2013EP2662370A1 5-Halogenopyrazole benzofuranyl carboxamides
11/13/2013EP2662369A1 benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device
11/13/2013EP2662368A1 Aromatic heterocycle derivative and organic electroluminescent element using same
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2662365A1 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661431A2 Heterocyclic compounds for the inhibition of pask
11/13/2013EP2661426A1 Pyrazol-4-yl carboxamide derivatives as microbiocides
11/13/2013EP2661424A1 Chemical compounds
11/13/2013EP2661265A1 Quinolines and aza-quinolines as crth2 receptor modulators
11/13/2013CN103391936A Anticancer agent
11/13/2013CN103391932A Heterocyclic compounds for the inhibition of pask
11/13/2013CN103391925A 5-halogenopyrazolecarboxamides
11/13/2013CN103389621A Oxime ester sulfonate type photo-acid generator
11/13/2013CN103387572A Reference marker for everolimus impurity detection and preparation method thereof
11/13/2013CN103387538A Synthesis method of quinoline derivative
11/13/2013CN103387535A Substituted alkynylpyridine compound, and application method and use thereof
11/13/2013CN102267990B 2,3-dihydrobenzofuran derivatives as well as preparation method and application thereof
11/13/2013CN102260249B (-) doxazosin mesylate type II crystal as well as preparation method and application thereof
11/13/2013CN102105451B Glucokinase activators
11/13/2013CN101918386B 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
11/13/2013CN101687844B Imidazole derivatives as CCR2 receptor antagonists
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580834 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/12/2013US8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
11/12/2013US8580795 Heterocyclic compounds as phosphodiesterase inhibitors
11/12/2013US8580791 Antiviral 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole bis-dihydrogen-phosphate salts
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/12/2013CA2607917C Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/12/2013CA2606683C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/12/2013CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof
11/07/2013WO2013165192A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013165189A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164801A1 Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals
11/07/2013WO2013164794A1 Crystalline forms of vilazodone hydrochloride
11/07/2013WO2013164337A1 New compounds and new use
11/07/2013WO2013164292A1 Indanyloxydihydrobenzofuranylacetic acids
11/07/2013WO2013164245A1 Plant growth regulating compounds
11/07/2013US20130296563 Methyltetrazole sulfides and sulfones
11/07/2013US20130296561 Process for the preparation of statins in the presence of base
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
11/07/2013US20130296375 Macrocyclic picolinamides as fungicides
11/07/2013US20130296374 Use of pro-fungicides of uk-2a for control of black sigatoka
11/07/2013US20130296373 Macrocyclic picolinamides as fungicides
11/07/2013US20130296371 Macrocyclic picolinamides as fungicides
11/07/2013US20130296369 Cyanoenamines and their use as fungicides
11/07/2013US20130296364 Modulators of atp-binding cassette-transporters
11/07/2013US20130296363 Quinoline and isoquinoline derivatives for use as jak modulators
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296333 Hedgehog pathway modulators
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130296327 Substituted heterocylic compounds
11/07/2013US20130296318 Compounds and compositions as protein kinase inhibitors
11/07/2013US20130296311 Inhibitors of hcv ns5a
11/07/2013US20130296309 Aryl pyridine as aldosterone synthase inhibitors
11/07/2013US20130296304 Tricyclic fused ring inhibitors of hepatitis c
11/07/2013US20130296300 Quinolines and aza-quinolines as crth2 receptor modulators
11/07/2013US20130296296 2-Carboxamide-7-Piperazinyl-Benzofuran Derivatives
11/07/2013US20130296295 Bcl-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/06/2013EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/06/2013EP2660240A1 Benzopyrone estrogen receptor regulator
11/06/2013EP2658854A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
11/06/2013EP2658848A1 New biaryl amide derivatives
11/06/2013CN103384665A Process of making gyrase and topoisomerase IV inhibitors
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN103382376A Treatment method of TGIC by-product and utilization method for obtaining adhesion agent by utilizing same
11/06/2013CN103382202A Compound containing furan substitute and preparation method and use thereof
11/06/2013CN103382201A Heteroaryl derivatives as cftr modulators
11/06/2013CN103382200A Preparation method of S-glycidylphthalimide
11/06/2013CN103382197A N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
11/06/2013CN103382196A (E)-1-(8-benzopyranyl)-2-allyl-1-one and its analogues, and use thereof
11/06/2013CN102174039B Preparation method of high-optical-purity pitavastatin calcium key intermediate
11/06/2013CN102099350B Novel herbicides
11/06/2013CN101522659B Fungicide N-cycloalkyl-carboxamide, thiocarboxamide and N-substituted-carboximidamide derivatives
11/05/2013US8575209 Modulators of ATP-binding cassette transporters
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575168 Compounds and compositions as modulators of GPR119 activity
11/05/2013US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
11/05/2013US8575161 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
11/05/2013US8574563 Hepatitis C virus inhibitors
11/05/2013CA2633207C Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
11/05/2013CA2481202C Functionalized ionic liquids, and methods of use thereof
10/2013
10/31/2013WO2013163270A1 Hepatitis c virus inhibitors
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013162284A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013160419A1 Novel compounds
10/31/2013US20130289117 Hydroxyl compounds and compositions for cholesterol management and related uses
10/31/2013US20130289090 Indole derivatives and process for their preparation
10/31/2013US20130289086 Aminopyrrolidinone Derivatives and Uses Thereof
10/31/2013US20130289075 Iap binding compounds
10/31/2013US20130289074 New indanyloxydihydrobenzofuranylacetic acids
10/31/2013US20130289050 Inhibitors of beta-secretase
10/31/2013US20130289042 Dimeric iap inhibitors
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 694